Risk of mortality in patients with cancer who experience febrile neutropenia

BACKGROUND: Febrile neutropenia (FN) is a serious and potentially life‐threatening condition that may develop in patients with cancer who receive myelosuppressive chemotherapy. The risk of mortality from FN is not well characterized in current clinical practice. METHODS: Patients with cancer who wer...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 2010-12, Vol.116 (23), p.5555-5563
Hauptverfasser:	Lyman, Gary H., Michels, Shannon L., Reynolds, Matthew W., Barron, Rich, Tomic, Karen Smoyer, Yu, Jingbo
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - adverse effects Biological and medical sciences Bone Marrow - drug effects Cancer Chemotherapy Complications Drug toxicity and drugs side effects treatment Female Fever - etiology Health care Hospitalization Humans infection Lung Male Medical sciences Middle Aged Mortality Neoplasms - drug therapy neutropenia Neutropenia - chemically induced Neutropenia - mortality non-Hodgkin's lymphoma Ovarian carcinoma Pharmacology. Drug treatments propensity score Retrospective Studies Risk Time Factors Toxicity: blood Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!